Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Jul 5, 2016 · 10-Q · 35 days after period end · 0001640334-16-001295
| Metric | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|
| Net Income | -$5.05K | -$2.50K | -$8.15K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended May 31, 2016 · filed Jul 5, 2016 · 35 d after period end
